Safety Study of Anti-Programmed Death-Ligand 1 in Hematologic Malignancy

Clinical trial NCT01452334 · WITHDRAWN

Trial details

NCT number: NCT01452334
Sponsor: Bristol-Myers Squibb
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Hodgkin's Lymphoma Hodgkin Lymphoma Multiple Myeloma Chronic Myelogenous Leukemia

Start date: 2011-11-01
Primary completion: 2014-11-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.